Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
7/26/2022
Mobile Health Applications for Depression in China: A Systematic Revie...
7/22/2022
Lilly and Triastek Tie Up to Explore the Application of 3D Printing Te...
7/22/2022
AbbVie Terminates Early-stage Study of I-Mab's Antibody lemzoparlimab...
7/22/2022
CDE Solicits Comments on the Draft Technical Guidelines for Drug Regis...
7/22/2022
CDE Issues the List of Reference Formulations for GQCE Studies (56th B...
7/22/2022
Two Chinese Biotechs Raise Millions for Shingles Vaccine Candidates to...
7/22/2022
Novaremed Enters License Pact with NeuroFront for Non-opioid Neuropath...
7/22/2022
Drug R&D and Product Registration News Digest July 2022 (3)
7/21/2022
WuXi Biologics Plans to Build a Comprehensive CRDMO Center in Singapor...
7/21/2022
A Practical Review of the New Supporting Regulations of China's Anti-M...
7/21/2022
A Practical Review of the Amended Anti-Monopoly Law of China: Highligh...
7/21/2022
Draft "Regulation on Prohibition for Abuse of IP Rights to Exclude or ...
7/20/2022
China's Prospective Payment System: 3 Ways to Prepare
7/20/2022
Official Data: Chinese Pharma Growth Slows in H1/2022
7/19/2022
WuXi STA Opens a New Large Scale Continuous Manufacturing Plant
7/19/2022
China To Establish National Demonstration Zones For IPR Protection
7/19/2022
CNIPA: IP to Boost Bio-Economy Development in China
7/19/2022
WuXi AppTec Plans to Build a New Site in Singapore with Planned S$2B I...
7/19/2022
Brii Bio Announces Strategic Partnership with China Resources Pharma f...
7/19/2022
CDE Solicits Comments on the Draft Guidelines for Clinical Development...
7/19/2022
CDE Solicits Comments on the Draft FAQs for Rapid Reporting of Safety ...
7/19/2022
NHSA Issues New Notice to Further Strengthen Regulation of Medical Ser...
7/18/2022
Pharmanovia Expands Its Footprint in China With The Acquisition of Roc...
7/18/2022
Beijing's Top Health Official Fired for Corruption
7/18/2022
Unicycive Enters License Deal with Lee's Pharma for Renazorb in China ...
7/18/2022
Chugai's Osteoporosis Agent Edirol Launched in China
7/18/2022
NHC's 2021 Annual Health Sector Development Report (Full Summary)
7/18/2022
June Approvals See China's First Greenlight Based Entirely on Real-Wor...
7/18/2022
How China's Big Pharma Bet Could Change Intellectual Property Game
7/18/2022
Incidence and Mortality Trends of Nasopharynx Cancer from 1990 to 2019...
Page:
77
/
719
Total number of articles:
21546
:
[First]
[<<]
[75]
[76]
[77]
[78]
[79]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit